News

Summarizing what was done in 2022 and outlining the plans for 2023, the European Medicines Verification Organisation (EMVO) in cooperation with the National Medicines Verification Organisations has published the EMVS Community Newsletter – 2022 Holiday Bulletin edition. In this bulletin, Inese Erdmane, Chairwoman of the Board at the Latvian Medicines Verification Organisation (LZVO), also talks about this year's achievements.

The European Medicines Verification Organization (EMVO) has launched a Newsletter, which introduces to the criteria that allow the identification of the "critical countries" of the system, tells about Romania's verification experience and other current issues of the system.

The European Medicines Verification Organization (EMVO) has launched a newsletter, which informs about the National Medicines Verification Organization (NMVO) and the European Change Control Board (EU CCB) created by the EMVO, various working groups – IT, quality, as well as the Inter-Operability Testing group, which allows for more efficient management of the medicines verification system and improvement of its development in all Member States.

The Latvian Medicines Verification Organization (LZVO) held three seminars on the current affairs of the Medicines Verification System in Latvia in September, directly addressing and informing more than 130 participants from 117 companies.

Latvijas Zāļu verifikācijas organizācija (LZVO) septembrī rīkoto bezmaksas semināru ciklu noslēdza ar diviem semināriem gala lietotājiem par zāļu verifikācijas sistēmas aktualitātēm Latvijā.

Latvijas Zāļu verifikācijas organizācija (LZVO) septembrī rīkoja bezmaksas semināru ražotājiem par Zāļu verifikācijas sistēmas aktualitātēm Latvijā, tieši uzrunājot un informējot 40 dalībniekus no 34 uzņēmumiem.